Human Immunodeficiency Virus Type 1 (HIV-1) antibody

Catalog No. ABIN2859503

This Mouse Monoclonal antibody specifically detects Human Immunodeficiency Virus Type 1 in WB, EIA, IF, IHC (fro) and ELISA (Capture). It exhibits reactivity toward Human Immunodeficiency Virus (HIV).

Quick Overview for Human Immunodeficiency Virus Type 1 (HIV-1) antibody (ABIN2859503)

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Reactivity: Human Immunodeficiency Virus (HIV)

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro)), ELISA (Capture)

Clone: 491

Product Details

Purification: Protein A Chromatography

Immunogen: Purified native p24.

Isotype: IgG1

Application Details

Application Notes: Suitable for use inELISA (1: 20 - 1: 200)Immunofluorescence (1: 10 - 1: 50)Western blot (1: 10 - 1: 50)Immunohistochemistry on frozen tissues (1: 10 - 1: 50). Not suitable for use with paraffin embedded tissues.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 0.1 mg/mL (OD280 nm, E0.1% = 1.3)

Buffer: 0.01 M PBS, pH 7.2, 0.09 % Sodium Azide, None

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Alternative Name: HIV-1

Target Type: Virus

Background: HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1